Introduction
Coronary heart disease (CHD) and chronic kidney disease (CKD) are important public health concerns. CHD is the leading cause of death [1] , and 26 million Americans with CKD are more likely to progress to CHD and premature death due to CHD than progress to kidney failure [2] . Multiple studies support the role of periodontal disease in contributing to a chronic systemic inflammatory burden in both CHD and CKD. A consensus report simultaneously published in the Journal of Periodontology and American Journal of Cardiology recommended that periodontists inform patients with periodontal disease they may have increased risk for cardiovascular disease and that cardiologists recommend patients have oral health checkups [3 ,4 ] . Chronic inflammation also contributes to the pathogenesis of hypertension and diabetes, both major risk factors for both CHD and CKD [5] . Healthcare personnel advise patients to reduce CHD and CKD risk through smoking cessation, diet modification, exercise, and antihypertensive drug therapy, as well as good glycemic control for individuals with diabetes. This review examines the evidence for the role of periodontal disease in CHD and CKD to assist healthcare providers as they consider adding home self-care and referrals for periodontal assessment and therapy to their repertoire of recommendations to improve patient's oral health and thereby possibly reduce risks for CHD and CKD.
Definitions
First, we will define the key terms central for this review.
Periodontal disease
The term 'periodontal diseases' has been used for years to include all diseases of the soft and hard tissue surrounding the teeth (i.e. the periodontium), including gingivitis, which is a reversible infection of the soft tissue without permanent loss of periodontal support. Chronic periodontitis, henceforth referred to as periodontal disease, is a chronic bacterial infection that causes a persistent host inflammatory response with destruction of the bone and soft tissue surrounding teeth, leading to tooth mobility and ultimately to loss of teeth. In adults, periodontal disease is a major cause of tooth loss, hence edentulism can be regarded as a marker of past periodontal disease [6] . Observational and interventional studies use various combinations of clinical and/or radiographic measures of extent and/or severity of gingival bleeding, probing pocket depth, attachment loss, and radiographic bone loss in specifying case definitions for periodontal disease [7, 8] . When studying the possible role of periodontal disease in systemic conditions, we believe that it is the inflammatory component of periodontal disease that is important. Thus, a useful clinical measure of active periodontal disease is one that incorporates bleeding on probing as a measure of active inflammation in combination with clinical attachment loss [9,10
,11] and/or probing pocket depth [12] . Additional definitions of periodontal disease that may be important to studies of the systemic effect of periodontal disease are based on serological antibody titers to periodontal pathogens [13 ,14,15] or clinical measures shown to correlate well with periodontal pathogen antibodies and inflammatory markers [12] .
Coronary heart disease CHD, as used in this review, refers to atherosclerosis of the coronary arteries leading to insufficiency of the myocardial blood supply due to reduction of blood flow through one or more of the coronary arteries or its branches [16] . Myocardial infarction, angina pectoris, and ischemic heart disease will be included as CHD in this report [1] .
Chronic kidney disease CKD is currently defined by the National Kidney Foundation's Kidney Disease Outcome Quality Initiative's (K/DOQI) classification of five stages of increasing severity of CKD based on kidney damage (microalbuminuria) and decreasing kidney function measured as glomerular filtration rate [17] .
Risk marker
A risk marker is an attribute or exposure that is associated with an increased probability of disease but not necessary a causal factor [18] . Thus, a risk marker can be determined based on cross-sectional data. Because most studies of the association between periodontal disease and CHD and CKD are of cross-sectional design, we refer to these factors as 'risk markers'.
Conceptual model linking periodontal disease with coronary heart disease and chronic kidney disease
The conceptual model shown in Fig. 1 is a simplified framework linking periodontal disease with CHD and CKD. Chronic inflammation elicits the acute-phase response and other inflammatory mediators that are common risk markers for CHD and CKD [5] and has a fundamental ongoing role in atherosclerosis [19] . As a chronic infection, periodontal disease contributes to the cumulative chronic inflammatory burden through the systemic dissemination of inflammatory mediators produced during the local tissue destructive immune-inflammatory response to periodontal pathogens as well as the systemic dissemination of the periodontal pathogens and their products (e.g. lipopolysaccharides) [20] .
The link between periodontal disease and CKD may be bidirectional, as evidence is emerging to suggest uremia may contribute to increased gingival inflammation in patients on dialysis [21 ] . Parenthetically, this bidirectional association is similar to the bidirectional relationship between periodontal disease and diabetes [22] . Kidney disease, by virtue of uremia or other mechanisms, may predispose to periodontal disease. The systemic inflammatory burden of periodontal disease may contribute to endothelial injury and atherogenesis [23 ,24] . The link between CHD and CKD may also be bidirectional. CKD is a well established risk factor for CHD [2, 5, 17, 25] and clinical atherosclerosis and heart failure have recently been shown to be independently associated with rapid kidney function decline [26 ] . It is noteworthy that adults with CKD are more likely to progress to cardiovascular events including CHD and heart failure, than to kidney failure [25] . Empirical evidence to support the conceptual model
Next, we will briefly describe the scientific evidence supporting each specific component of our conceptual model.
Bacteremia
The periodontal pathogenic bacteria and their byproducts (e.g. lipopolysaccharides) translocate via bacteremia after they easily penetrate the inflamed, ulcerated gingival tissue surrounding the teeth and enter the bloodstream, by which they are dispersed systemically and elicit host responses in distal tissues and organs.
Researchers have found periodontal pathogenic bacteria in atherosclerotic plaque [27, 28] and in the arterial walls [29, 30] . Periodontal pathogens are associated with endothelial dysfunction [31] .
Periodontopathogen-specific immune response
Elevated Porphyromonas gingivalis antibody titers have been found to be independently associated with periodontal disease, and high Eubacterium nodatum titers were associated with periodontal health [13 ] . Two other studies also found those with periodontal disease had higher P. gingivalis antibody titer levels, as well as those with CHD [32 ,33] . Periodontopathogen antibody titers are shown to be associated with subclinical atherosclerosis as measured by carotid intima-media thickness (IMT) [20] and with CHD and CHD death [34] . Whereas higher P. intermedia antibody levels have been found in acute coronary syndrome and coronary artery disease (CAD), suggesting that infection of an atheroma by periodontopathogens may trigger the acute coronary syndrome [11] . Interestingly, antibody titers to Aggregatibacter actinomycetemcomitans, another periodontal pathogen, have been reported to have an independent negative [6] and positive association [35] with CKD. The current evidence from these few reports remains inconclusive but support conduction of further investigations to determine the value of measuring antibody titers to periodontal pathogenic bacteria in studying the role of periodontal disease in the pathogenesis of CHD and CKD.
Diabetes duration, glycemic control, and insulin resistance Diabetes must be considered in an evaluation of the relationships between periodontal disease and CHD and CKD because these three diseases are recognized as complications of diabetes. Further, rigorous management of glycemic control reduces the risk of CHD and CKD in people with diabetes [36] , and evidence is emerging that nonsurgical periodontal therapy significantly contributes to improvement in glycemic control [36, 37 ]. As indicated in the conceptual model (see Fig. 1 ), there are both direct and indirect effects of diabetes on CHD and/or CKD, with the indirect effects occurring through hypertension [38] and atherosclerosis [39] . In addition, insulin resistance has also been discussed as the metabolic link for periodontal disease contributing to poorer glycemic control in diabetes [40] .
Hypertension
It is well established that hypertension increases the risk for CHD and CKD occurrence, progression, and mortality [5, 41 ], as does lower blood pressure in dialysis patients. Relevant to this review, in cross-sectional studies of moderate-to-severe CKD (stages 3 and 4) [6, 10
,42] and kidney transplantation [43] , those with hypertension were twice as likely to have CKD than those without hypertension after simultaneously taking into account other statistically significant risk markers, including periodontal disease. A large cross-sectional study provides the first population-based evidence for a direct relationship between the amounts of pathogenic subgingival periodontal bacteria and systolic and diastolic blood pressure, respectively, as well as prevalent hypertension [44 ] .
Atherosclerosis
Our review focuses on two main measures of subclinical atherosclerosis, namely endothelial dysfunction and IMT.
Endothelial dysfunction
The inability of arteries and arterioles to dilate (endothelial dysfunction) is a key event in the development of atherosclerosis and precedes clinically obvious vascular pathology by many years. Endothelial dysfunction predicts myocardial dysfunction. Brachial artery flowmediated dilation is a noninvasive measurement of endothelial dysfunction. A randomized controlled trial (RCT) of intensive periodontal therapy showed significant improvement of flow-mediated dilation [31] , suggesting a causal link between periodontal disease and endothelial dysfunction as an indicator of early atherosclerosis in otherwise healthy individuals affected by severe periodontal disease. In order to elucidate the mechanisms involved, another study investigated the association between periodontal disease and circulating endothelial progenitor cells as markers for endothelial dysfunction [45 ] . This study showed, for the first time, that moderate-to-severe periodontal disease was associated with an increased level of circulating endothelial progenitor cells which were also associated with C-reactive protein (CRP).
Intima-media thickness
IMT is a measure of subclinical atherosclerosis. A small study of 35 people with mild-to-moderate periodontal disease found nonsurgical periodontal therapy reduced levels of inflammatory markers and IMT [23 ] . Evidence of a direct relationship between periodontal disease and IMT was first demonstrated among 657 dentate patients, when individuals with greater quantities of periodontopathogens had higher mean IMT than individuals with lower quantities. This relationship was independent of CRP and was specific for pathogenic periodontal bacteria [46] . No change in CRP level was found after treating obese individuals but significantly fewer nonobese participants had CRP at least 3 mg/l following periodontal treatment. Periodontal therapy did not decrease CRP levels among individuals with CRP levels less than 3 mg/l at baseline. The authors suggested that obesity increased CRP levels and nullified any periodontal treatment effects on CRP reduction.
In addition to CHD, higher CRP levels are independently associated with more rapid loss of kidney function [50] . African-Americans are more likely to have CKD than nonHispanic whites. (Race/ethnicity is another risk marker in the conceptual model depicted in Fig. 1.) Only limited data exist for this racial disparity, which is not fully explained by the higher rates of hypertension, diabetes, and obesity. Hence, an important study is the large crosssectional study of 4320 African-Americans in the Jackson Heart Study, which investigated the role of inflammation in CKD and found CRP was independently associated with CKD but not significantly associated with albuminuria [51 ] . This finding adds to the researchers, earlier finding that CRP level is heritable after adjusting for age, sex, and body mass index [52] .
A meta-analysis reported strong evidence for elevated CRP in people with periodontal disease compared to those without periodontal disease and modest evidence for the effect of nonsurgical periodontal therapy decreasing CRP levels [53] . A small RCT showed for the first time that nonsurgical periodontal treatment caused a simultaneous reduction in plasma levels of CRP, interleukin (IL)-6, and fibrinogen in patients with severe periodontitis and severe nonresponsive arterial hypertension under medical treatment [54 ] . A large populationbased study of 4830 Scottish adults found those who never or rarely brushed their teeth had an increased concentration of both CRP and fibrinogen [55 ] . A recent case-control study of 68 cases with severe periodontal disease and 48 periodontally healthy controls found periodontal disease was associated with increased levels of CRP, glucose, fibrinogen, and IL-18, and with decreased levels of IL-4 [56 ] . However, a study of dialysis patients found no association between moderate-to-severe periodontal disease and CRP or with serum albumin [57 ] , even though those with moderate-to-severe periodontal disease were five times more likely to die from cardiovascular events than those with no or mild periodontal disease. An earlier study by these researchers found that severe periodontal disease was associated with serum albumin but not with CRP [58] . An RCT found no significant difference in levels of CRP, IL-6, and plasminogen activator inhibitor-1 between an intensive periodontal treatment group and the community-based periodontal care control groups at 2-month and 6-month follow-up examinations [31] . In another study, provision of comprehensive therapy to 30 patients with severe periodontal disease resulted in alterations in several inflammatory biomarkers that varied greatly and inconsistently among individuals. These changes were unrelated to severity of the periodontal infection and seemed to depend more on the inflammatory host response. The authors point to atherosclerotic status as a reasonable candidate to investigate as a confounder [59 ] .
Other risk markers
Additional risk markers common to CHD and CKD include smoking, age, race/ethnicity, low income/education, cholesterol, high-density lipoprotein, and obesity [17, 41 ] . However, the traditional factors explain only about half the deaths from CHD [60] , and almost half of all heart attacks occur in patients without the classic Framingham study risk factors [61] .
A candidate-gene association study demonstrated that CHD and periodontal disease are genetically related by at least one susceptibility locus, and this shared genetic susceptibility locus did not appear to be modified by the common risk factors for CHD and periodontal disease. Hence, the authors conclude that the association between these common inflammatory complex diseases could be partially due to a shared genetic cause, thus providing new insight into the underlying partially shared pathogenic mechanisms of these complex common diseases [62 ] .
Empirical evidence of the role of periodontal disease in coronary heart disease
The effects of periodontal disease and treatment of periodontal disease are described under the respective headings of the main risk marker measured. A growing body of epidemiologic evidence supports an association between clinically diagnosed periodontal disease and CHD [63] , and recently the strength of the evidence for this biologically plausible association was found to be insufficient for, but suggestive of, a causal relationship [64 ] . Meta-analysis of 22 case-control and cross-sectional studies and 12 cohort studies concluded that the risk for ischemic cardiovascular disease was significantly higher among individuals with periodontal disease [65 ] . A large cross-sectional study of women [66] and a large prospective study of men and women with 12 years follow-up [67 ] did not find a statistically significant relationship between probing pocket depth or periodontal disease and CHD but found a significant association between tooth loss and increased risk for CHD and CHD mortality.
A US cohort study with an average of 2.9 years follow-up of men and women with a history of myocardial infarction showed that loss of periodontal attachment level independently predicts recurrent cardiovascular events among analyses restricted to never-smokers [68 ] . Similarly, a longitudinal study of patients with acute coronary syndrome reported periodontal disease was strongly associated with both first events and acute coronary syndrome recurrence [69 ] . A case-control study of CAD and non-CAD found that periodontal disease was independently associated with CAD [70] .
Empirical evidence of the role of periodontal disease in chronic kidney disease
The evidence for the role of periodontal disease in CKD prevalence and progression stems mainly from population-based cross-sectional studies, and case-control and smaller clinical studies. The effects of periodontal disease have been described under the respective headings of the main risk marker measured. In the context of studies on the relationship between periodontal disease and CKD, a population-based cross-sectional study found that periodontal disease or its severe consequence, edentulism, was independently associated with CKD after adjusting for 11 other traditional and nontraditional risk factors [6] . This study is noteworthy because it provided evidence for the importance of simultaneously taking into account other risk factors rather than identifying high-risk subgroups based on a single risk factor. In addition, the dose-response for periodontal status was reported such that the odds of CKD increased as the severity or extent of periodontal disease increased. This finding is similar to an earlier longitudinal study of 529 Gila River Indian Community adults with type 2 diabetes that found a dose-response between periodontal disease (none or mild periodontal disease, moderate periodontal disease, severe periodontal disease, and edentulous) and incidence of macroalbuminuria and end-stage renal disease [71] . Another key finding is a prediction model for CKD in which periodontal disease or edentulism was a significant predictor, after controlling for the effect of diabetes (duration), in addition to controlling for high CRP level and eight other commonly recognized risk markers for CKD [10 ] . Most importantly, the beta coefficients and formula provided in this report provide the opportunity to estimate anyone's probability of CKD based on their specific characteristics as expressed by the presence or absence of 12 risk markers.
A highly relevant study of dialysis patients investigated the role of periodontal disease in CHD (thus incorporating all three diseases under review) using a welldesigned retrospective 18-month follow-up study of 168 dentate adults. The important finding was that patients on dialysis with moderate-to-severe periodontal disease were five times more likely to die from cardiovascular disease than those with no or mild periodontal disease [57 ] .
Limitations to causal inferences
The major limitation to making unequivocal statements regarding the causal role of periodontal disease in the pathogenesis or progression of CHD and CKD is the inability to establish causality due to the cross-sectional study design of most of the large, population-based reports. Other limitations are the small number and lack of consistent findings from well designed prospective studies, including clinical trials that control for important confounders and effect modifiers, such as smoking, diabetes, hypertension, and obesity.
Conclusion
Although the evidence linking periodontal disease with CHD and CKD is not yet conclusive, recent evidence strengthens support for the biologically plausible role of periodontal disease in the occurrence and progression of CHD and CKD. To better understand the complex relationships between periodontal disease, CHD, and CKD, additional well-designed prospective cohort and controlled intervention studies are needed. Nevertheless, adding personal oral hygiene and referral for professional periodontal assessment and therapy to the repertoire of medical care recommendations is prudent to improve patients' oral health and possibly reduce CHD and CKD risk. The guidelines in this unique consensus report by expert periodontists and cardiologists are paradigm-changing in their recommendation that medical and dental healthcare providers should closely collaborate in managing their mutual patients. Each recommendation is for a specific patient category and comes with scores of levels of confidence and evidence type, respectively. With an estimated 75% of 7 million Americans with moderate-to-severe CKD undiagnosed, this US population-based study of 11 955 adults is important because the prediction model identified high-risk subgroups for CKD. The most interesting aspects of this model are that periodontal disease is included, and it allows individuals or healthcare providers to estimate anyone's probability of CKD using the provided formula and beta-coefficients for each of the 12 risk markers: age, race/ethnicity, periodontal status, smoking status, duration of diabetes, and presence/absence of hypertension, macroalbuminuria, high cholesterol, low highdensity lipoprotein, high CRP, lower income, and whether they were hospitalized in the past year. 
